PWA
VSTM icon

Physician Wealth Advisors’s Verastem VSTM Stock Holding History

Physician Wealth Advisors’s Portfolio VSTM Stock Details VSTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-111
Closed -$589 – 2463
2026
Q1 		$589 Buy
+111
New +$685 ﹤0.01% 1860
2025
Q2 		– Sell
-95
Closed -$573 – 1991
2025
Q1 		$573 Buy
+95
New +$580 ﹤0.01% 1354

Other funds holding VSTM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Physician Wealth Advisors's VSTM Position: Q2 2026 in Review

Physician Wealth Advisors sold out of Verastem (VSTM) in Q2 2026, closing a stake of 111 shares — an estimated $589 sold.

Physician Wealth Advisors first reported a position in VSTM in Q1 2025 and held it in 2 quarters. The position peaked at $589 in Q1 2026. 157 funds tracked by Wall St. Rank hold VSTM as of Q2 2026.

  • Physician Wealth Advisors reported no remaining Verastem position as of Q2 2026 after selling out during the quarter.
  • Physician Wealth Advisors sold 111 Verastem shares in Q2 2026, an estimated $589.
  • Physician Wealth Advisors first reported a position in Verastem in Q1 2025 and held it in 2 quarters.
  • Physician Wealth Advisors's Verastem position peaked at $589 in Q1 2026.
  • 157 funds tracked by Wall St. Rank held Verastem as of Q2 2026.

Based on Physician Wealth Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.